Navigation Links
BD and FIND Achieve Milestone in Global Battle Against MDR-TB
Date:6/17/2009

Price reductions for liquid culture tests will accelerate access to improved TB diagnostics

SEATTLE, June 17 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company; NYSE: BDX), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics), a Swiss foundation that develops, evaluates and accelerates the implementation of new diagnostic tools for poverty-related diseases, today announced a significant price reduction in the cost of liquid culture testing.

The agreement lowers the cost of BD MGIT(TM) reagents. BD's TB diagnostic technologies utilize liquid culture, a key "standard of care" TB testing protocol that provides results far faster than traditional, solid media culture. The liquid culture test, widely used in modern research settings, is particularly effective for stemming the spread of multi-drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) in developing countries.

"By collaborating with such leading global health organizations as FIND, BD's Global Health initiative implements diagnostic programs that help strengthen healthcare infrastructures in developing countries," said Krista Thompson, Vice President and General Manager, Global Health, BD. "With an emphasis on accessibility, affordability and sustainability, BD provides on-the-ground technical assistance, training and products that maximize the capacity to diagnose TB, including drug-resistant strains, in nations where the disease is most prevalent."

The price reduction -- announced five months earlier than anticipated -- arises from a November 2007 agreement between BD and FIND. At that time, BD agreed to reduce already below-market prices upon the completion of 3.5 million tests, a milestone achieved this month. The lower prices will enable more tests to be administer
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. Pharsight Achieves First License Sale for Public-Source Database
3. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
4. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
5. Signalife Achieves $1.98 Million Sales Orders Thus Far
6. Australian Therapeutics Goods Administration Approval for ActiPatch Achieved
7. Korean Food and Drug Administration Approval for ActiPatch Achieved
8. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
9. UD researchers race ahead with latest spintronics achievement
10. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
11. Dragon Announces R&D Achievement in Biotech Manufacturing Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... April 16, 2015 Cytokinetics, Incorporated (Nasdaq: ... first quarter results on Thursday, April 30, 2015 at ... management will host a conference call at 4:30 PM ... the company’s outlook for the future. , The conference ... from the homepage and in the Investor Relations section ...
(Date:4/16/2015)... Proove Biosciences , Inc. is ... Contest for the 2015 BIO International Convention. Hosted ... International Convention will take place June 15-18 at the ... of BIO contest, industry leaders will be voting for ... conference. The community voting period began on April 14, ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2
... LAKES, N.J., June 1 BD (Becton, Dickinson and Company) (NYSE: BDX ), ... healthcare conferences in June: , , Goldman Sachs ... 11:40 a.m. EDT, ... June 11, 2009, 10:00 a.m. EDT, , ...
... ARBOR, Mich., June 1 Assay Designs, Inc., a ... the life science and translational research markets, has announced ... dedicated to the analysis of heat shock proteins and ... , The bead-based multiplex immunoassay enables measurement of ...
... Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin ... the first patient in its Phase 2b clinical ... of California, San Diego ("UCSD"), to evaluate ... in nephropathic cystinosis ("cystinosis"), a rare genetic lysosomal ...
Cached Biology Technology:Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 5
(Date:4/10/2015)... 10, 2015 Research and Markets ... "Security Competitive Profiles - NEC" report to ... NEC will continue to supply a range of ... with a company focus on the development of a ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Medicine uses PET, radiotracer to track enzyme in smokers, ... in the lungs, possibly contributing to some of smoking's ... the September issue of the Journal of Nuclear Medicine. ... enzyme, also shows that smokers had a lower concentration ...
... of Pennsylvania School of Medicine found that a protein ... development of hematopoietic stem cells (HSC), or blood-producing stem ... pathway may one day lead to new treatments for ... better understanding of how HSCs work in the context ...
... A new study of 60 beaches in Southern California ... reaching the highest levels when tides are ebbing during ... beachgoers and managers better assess the potential risk of ... issue of the American Chemical Society's journal Environmental Science ...
Cached Biology News:Smoking damages key regulatory enzyme in the lung 2Smoking damages key regulatory enzyme in the lung 3Master regulatory gene found that guides fate of blood-producing stem cells 2Beach pollution is worst during new and full moon 2
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...
... polystyrene with frosted labeling surfaces, volume ... counting. 100% integrity tested. Linkage: This ... number, created to easily match Cornings ... yet, please order under the old ...
... ® Ek Adaptor encodes a T7 ... site (rbs), ATG translation initation codon, and ... is a small epitope tag (11 aa) ... target protein with T7•Tag Monoclonal Antibody and ...
Biology Products: